06/19/2012 - 9:00am

Pfizer announced the results of its late-stage clinical trial of Xalkori (crizotinib).

06/19/2012 - 8:47am

The Food and Drug Administration has declined to approve a drug designed to treat a rare, progressive and fatal neurodegenerative disease.

06/19/2012 - 8:17am

AstraZeneca and Rigel Pharmaceuticals have entered an exclusive worldwide license agreement for the global development and commercialization of an investigational treatment for moderate to severe chronic asthma.

06/18/2012 - 12:33pm

Americans still are forgoing or delaying health care on account of the economy, according to the Kaiser Family Foundation, which recently released its May Health Tracking Poll.

06/18/2012 - 11:35am

A healthcare company and a drug maker have entered a one-year research partnership to explore diabetes treatment and care.

06/18/2012 - 8:40am

Merck announced that the U.S. District Court for the District of New Jersey ruled against the company in a patent infringement suit against Canada-based drug maker Apotex.

06/18/2012 - 7:50am

A nonprofit global health and disaster relief organization has recognized a drug maker for its commitment to aiding disaster survivors and increasing access to health care around the world.

06/15/2012 - 10:12am

Valeant Pharmaceuticals International has agreed to acquire a specialty oral health company that develops and commercializes products that improve and maintain oral health.

06/15/2012 - 10:08am

GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.